Our global community is at the forefront of biology and technology and is dedicated to transform healthcare and help people live healthier, better lives. Join us!
Who we are
aMoon is a leading HealthTech and Life Sciences venture capital fund based in Israel. Our mission is to launch tomorrow’s cures to the world’s greatest healthcare challenges. We are passionate about giving the most promising thinkers and innovators the resources they need to propel their business and technology to the next level and beyond. The largest HealthTech fund in Israel with over $1billion under management, our mission is to harvest the tsunami of the convergence of health and technology in Israel and globally and to accelerate cures for humanity’s most life-threatening conditions and global healthcare’s biggest cost drivers.
The aMoon team combines the forces of a unique investment engine and a global network of investors and industry leaders to enable early and late-stage companies in the fields of biopharma, digital health and medical technology to achieve their fullest potential. We are a team of doctors, scientists, hi-tech pioneers and innovators ourselves. We are deeply passionate about working hand-in-hand with our portfolio companies to reshape global healthcare.
Velocity is aMoon’s early stage fund focused on identifying and enabling cutting-edge disruptive innovations through seed/round A investments, venture formation, sponsored research and strategic collaborations. Our team of industry and VC veterans, PhD scientists and business experts evaluates investment opportunities in Bio-Pharma, Devices & Diagnostics, and Health-IT and works closely with founders to navigate the greatest challenges and add significant value to company growth.
We are seeking an exceptional individual with a strong business acumen to screen, research and perform due diligence on the most advanced and innovative early stage investment opportunities. The Associate will conduct initial screening based on science/technology, financials and market need and will deliver comprehensive diligence including deep analysis of the technology, business model, market and financial aspects of the deal. Due diligence process will include review of preclinical, clinical and commercial data and research; conducting interviews with KOLs and domain experts to assess the unmet needs and relative strength of the product/technology to competition and assist with preparation of investment thesis and materials.
As part of his/her role, the Associate will also work with the industry and academics partners of the firm, as well as develop their own network, to source promising new leads for investment opportunities. Our associates work in multiple projects, in a team based and fast paced environment, assist board members with board meetings preparations and work with the Alpha group to add value to our portfolio companies.